A novel soluble complement receptor 1 fragment with enhanced therapeutic potential-Reference-Cited by-同舟云学术

A novel soluble complement receptor 1 fragment with enhanced therapeutic potential

Published:2021 Issue: Volume:296 Page:100200
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Wymann Sandra,Dai Yun,Nair Anup G.,Cao Helen,Powers Glenn A.,Schnell Anna,Martin-Roussety Genevieve,Leong David,Simmonds Jason,Lieu Kim G.,de Souza Mitchell J.,Mischnik Marcel,Taylor Shirley,Ow Saw Yen,Spycher Martin,Butcher Rebecca E.,Pearse Martin,Zuercher Adrian W.,Baz Morelli Adriana,Panousis Con,Wilson Michael J.,Rowe Tony,Hardy Matthew P.

Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference92 articles.

1. Complement: a key system for immune surveillance and homeostasis;Ricklin;Nat. Immunol.,2010

2. Complement--tapping into new sites and effector systems;Kolev;Nat. Rev. Immunol.,2014

3. Interaction between the coagulation and complement system;Amara;Adv. Exp. Med. Biol.,2008

4. The amplification loop of the complement pathways;Lachmann;Adv. Immunol.,2009

5. The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35);Liu;Immunopharmacol. Immunotoxicol.,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The complement system: A key player in the host response to infections;European Journal of Immunology;2024-08-27

2. Mechanistic insights into complement pathway inhibition by CR1 domain duplication;Journal of Biological Chemistry;2024-07

3. Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2021–2022;Mass Spectrometry Reviews;2024-06-24

4. The Production of Complement Inhibitor Proteins in Mammalian Cell Lines—Light at the End of the Tunnel?;Biomedicines;2024-03-14

5. Complement in human disease: approved and up-and-coming therapeutics;The Lancet;2024-01